Www.rtog.org 1 MARCH 2012 Regulatory Documents & the CTSU.

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Research Study Regulatory Binder Ronald Cowan, MD, PhD J. Gavin Lillevig, BS Summer Professional Didactics Data Management Psychiatric Neuroimaging Program.
National Cancer Institute Cancer Therapy Evaluation Program (CTEP) presents: How to Obtain Protected Health Information (PHI) from an Outside Healthcare.
THE UW HEALTH SCIENCES IRB S OVERVIEW PRACTICAL REGULATORY ISSUES IN HUMAN SUBJECTS RESEARCH.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program.
ACRIN Presentation Cancer Trials Support Unit Basics September 21, 2011 Martha Hering, RN, CCRP 21 Sept ACRIN Presentation.
Submission to Approval What happens to my protocol once I submit it to the HIC office.
CRC Protocol Documents Protocol Submissions Amendments Publications Study Closure.
Completing a Questionnaire B Form (and beyond…) Office of Research and Project Administration 1.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.

National Cancer Institute (NCI) Central Institutional Review Board (CIRB) Research Studies UCSF HRPP Submission Process Overview Tuesday, December.
Instructions for VCU’s Internal Approval Form Form is required to obtain Authorized Official’s signature on proposals and awards OSP – 8/2006.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
How to Obtain Institutional Review Board (IRB) Approval Richard Wagner Associate Director UCSF Human Research Protection Program August 14, 2008.
Working with Quorum Allina Health Megan Simpson, CIP Senior Study Manager Allina Account Manager.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Procurement Card Presented By: Denise Matias, CAH February 1, 2012.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
Nursing Research Project Idea? CALL Center for Nursing Research & Practice Is it research or quality improvement? Once your submission is.
Research: Intramural and Extramural Jacquelyn Goldberg, JD CIRB Review Board Administrator Clinical Investigations Branch, CTEP Division of Cancer Treatment.
SMART Study Closeout Washington ICC Meeting 03 June 2007.
 The IRB application  The Review Process  Summary of Protocol  Appendixes  Informed Consent  Recruiting materials  Research Instruments  Other.
Welcome to IRBManager! To access IRBManager, type the following address in your web browser:
How to Successfully Apply to the IRB Richard Gordin, IRB Chair True Rubal, Administrator / Director For the Protection of Human Participants in Research.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Welcome To INSPIR Training Please be sure Please be sure to sign- in to sign- in Please be sure you try to log – on to INSPIR before you leave Please be.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
Western Oregon University INSTITUTIONAL REVIEW BOARD.
LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
CTMB Guidelines (Rev. October 2006) Section 5: Conducting the Quality Assurance Audit.
Fully accredited since 2006 Tom Conquergood, CIP Working with Quorum October 13, 2015 Thomas Jefferson University.
Medidata Rave Start-Up Information
Ashley Carroll Verification Specialist
Opening An ETCTN Study at Your Site August Scope of this Presentation  This presentation applies to all sites which will be participating on.
1 MARCH 2012 REGULATORY MANAGEMENT Marie D’Amico, CCRP Manager, RTOG Regulatory Affairs.
Office of Human Research (OHR) Quality Improvement Program Patrick Herbison Heather Krupinski.
Ashley DiBlasi Certification Manager
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Participating in NCTN Studies NCI codes, Rosters, and Roles
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
REGULATORY MANAGEMENT
The Role and Responsibilities of the Clinical Research Coordinator
MAINTAINING THE INVESTIGATOR’S SITE FILE
Section 236 Program Year End Requirements Excess Income Reporting Annual Certification of Use (ACU) (for Retained Excess Income) Annual Certification.
Investigator of Record – Definition
Beverley Alberola, CIP Associate Director, Research Protections
Reportable Events & Other IRB Updates February 2017
Virtual Network Meeting: Consolidated Application
Investigator of Record – Definition
Investigator of Record – Definition
UW-Madison Central IRB Gateway
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Hands-On: FSA Assessments For Foreign Schools
TRTO (Translational Research Trials Office)
USF Research Integrity & Compliance
Central IRB Components of ARCADIA
Contract Requirements for Suppliers
Presentation transcript:

1 MARCH 2012 Regulatory Documents & the CTSU

2 Disclaimer The following presentation is being given for RTOG studies only. The information represented here while current may change due to changes within RTOG internal processes or because of federal regulatory guidelines. Therefore, you may not reproduce or distribute any of the presentation without obtaining RTOG’s prior written consent.

3 Regulatory Documents All regulatory documents for US, Canadian & Non North American sites are submitted to the CTSU for cataloguing and data entry –Continuing Reviews –Approvals of amendments –IRB initial study approvals –IRB approved consent forms (translation required for Non English speaking countries/provinces)

4 Continuing IRB Approval IRB approval must continue untilIRB approval must continue until Finite StudiesFinite Studies –All subjects accrued have completed treatment and follow up Non Finite StudiesNon Finite Studies –All subjects are deceased Additional requirements for both finite & non finite studiesAdditional requirements for both finite & non finite studies –No further accrual is anticipated –All data forms have been submitted –All queries to date have been resolved –RTOG approves the site for early closure (see form) IRB approval remains necessary, even after RTOG study closure and until RTOG termination unless all the above criteria/requirements have been metIRB approval remains necessary, even after RTOG study closure and until RTOG termination unless all the above criteria/requirements have been met Only RTOG can classify a study as "terminated" (Database locked)Only RTOG can classify a study as "terminated" (Database locked) Notification of Study Termination will be received via broadcastNotification of Study Termination will be received via broadcast A formal request is required for early closure when all criteria metA formal request is required for early closure when all criteria met

5 Form to Request Early IRB Closure

6 Requests for Early IRB Closure Request form must be submitted to and approved by RTOGRequest form must be submitted to and approved by RTOG The Form has Multiple purposesThe Form has Multiple purposes –Request consideration for early closure with IRB –Request closure with IRB when no patients enrolled on study –Transfer IRB responsibilities RTOG response with approval of the request is required prior to taking any closure actionRTOG response with approval of the request is required prior to taking any closure action Internal multi department review at RTOG HQ can take 7-10 business days to completeInternal multi department review at RTOG HQ can take 7-10 business days to complete Sites will still be required to respond to queries even after study closure with the IRBSites will still be required to respond to queries even after study closure with the IRB

7 Continuing IRB Approval IMPORTANT NOTE Full member institutions that have affiliates that use the Full Member IRB as their IRB of record must ensure that those affiliate/ Joint Center institutions had also never put any patients on studies they are considering closing with the IRB. If they have, then the main IRB must keep this study open for annual review.IMPORTANT NOTE Full member institutions that have affiliates that use the Full Member IRB as their IRB of record must ensure that those affiliate/ Joint Center institutions had also never put any patients on studies they are considering closing with the IRB. If they have, then the main IRB must keep this study open for annual review.

8 Special Handling Handling of all other study specific regulatory documentation is detailed in Sections 5.0 or 7.0 of the protocolHandling of all other study specific regulatory documentation is detailed in Sections 5.0 or 7.0 of the protocol Study Agent Shipment Form (SASF) Sponsor required documentation Questionnaires Training Certifications RT Certifications Non English speaking Canadian & Non North American sites are required to supply the Certified/Verified English translation and native language copy of the IC with their regulatory approvalsNon English speaking Canadian & Non North American sites are required to supply the Certified/Verified English translation and native language copy of the IC with their regulatory approvals Other special procedures may exist for Non North American sitesOther special procedures may exist for Non North American sites

9 Correlative Components Each participating institution must be prepared to participate in all correlative components/have a plan in place to facilitate participation and must offer every patient the opportunity to participate in these components.Each participating institution must be prepared to participate in all correlative components/have a plan in place to facilitate participation and must offer every patient the opportunity to participate in these components. ONLY THE PATIENT can decline to participate in the correlative components of a studyONLY THE PATIENT can decline to participate in the correlative components of a study The majority of RTOG studies require varying degrees of specimen collection as part of eligibility, stratification or protocol treatment.The majority of RTOG studies require varying degrees of specimen collection as part of eligibility, stratification or protocol treatment. Sites are encouraged to become more organized in their efforts and coordinate tissue banking collections with other protocol required specimen collections whenever possible.Sites are encouraged to become more organized in their efforts and coordinate tissue banking collections with other protocol required specimen collections whenever possible. In the event tissue is collected/residing at another facility RTOG expects a good faith effort to obtain the retrospective specimens but the site will not be penalized if it is not possible.In the event tissue is collected/residing at another facility RTOG expects a good faith effort to obtain the retrospective specimens but the site will not be penalized if it is not possible. Prospectively the site must inform the collecting entity that future specimens collected are expected to be forwarded along with the appropriate submission form for tissue banking as noted in the protocol.Prospectively the site must inform the collecting entity that future specimens collected are expected to be forwarded along with the appropriate submission form for tissue banking as noted in the protocol.

10 CTSU Forms & Guidance Can be found on the RTOG website under RA/Regulatory Info/CTSU Filing Requirements –IRB Certification Forms –310 Certification Form –IRB Transmittal Forms –Guidance for completing the forms –RSS Flow sheet NCI Required Forms are also available here –FDA 1572 –CTEP Supplemental Investigator Data Form (IDF) –CTEP Financial Disclosure

11 Proper Labeling Ensures Proper Processing Please identify all information submitted to the CTSU with the institution’s NCI Code on the transmittal/certification formPlease identify all information submitted to the CTSU with the institution’s NCI Code on the transmittal/certification form If the submission covers more than one institution or an entire CCOP all assigned individual NCI institution codes covered under the approval must be listed on the transmittal/certification form or supplemental pageIf the submission covers more than one institution or an entire CCOP all assigned individual NCI institution codes covered under the approval must be listed on the transmittal/certification form or supplemental page

12 CTSU Forms Transmittal/Certification

13 Resolving Regulatory Issues All issues for U.S., Canadian and Non North American sites with submitted regulatory documents should be handled directly through the CTSU.All issues for U.S., Canadian and Non North American sites with submitted regulatory documents should be handled directly through the CTSU. RTOG does not have access to copies of regulatory documents that have been submitted to the CTSU.

14 Checking Registration Status Visit the CTSU Website: Requires a CTSU username & passwordRequires a CTSU username & password Sites are identified by NCI CodeSites are identified by NCI Code Lists all requirements for studyLists all requirements for study Lists items not in complianceLists items not in compliance Now available for Non North American sitesNow available for Non North American sites

15 To obtain a CTSU password…

16 Points of Contact for the CTSU Help Desk: Help Desk: Regulatory Help Desk: CTSU (2878)Regulatory Help Desk: CTSU (2878) for questions: for questions: For Regulatory Submissions: Fax Number: Fax Number: : Mailing Address: Mailing Address: CTSU Regulatory Office Coalition of National Cancer Cooperative Groups 1818 Market Street, Suite 1100 Philadelphia, PA Website: